Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Escaping the Long Shadow Cast by Agranulocytosis
José de León, Manuel Arrojo, Hélène Verdoux, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 239-245
Closed Access | Times Cited: 20

Showing 20 citing articles:

Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis
Brian O’Donoghue, Francesco Piacenza, Helena Plapp, et al.
Schizophrenia Research (2024) Vol. 268, pp. 193-204
Open Access | Times Cited: 8
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
Carlos De las Cuevas, Emílio J. Sanz, José de León
Schizophrenia Research (2023)
Open Access | Times Cited: 16
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
Marina Šagud, Dagmar Breznoščáková, Andreja Čelofiga, et al.
Schizophrenia Research (2023) Vol. 268, pp. 53-59
Closed Access | Times Cited: 14
Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research
José de León
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 5
A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration
Olivia Carswell, Lisa R. Wilton, Kerri Nicholls, et al.
Schizophrenia Research (2023) Vol. 268, pp. 88-93
Open Access | Times Cited: 12
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Carlos De las Cuevas, Emílio J. Sanz, Jason A. Gross, et al.
Schizophrenia Research (2023) Vol. 268, pp. 175-188
Open Access | Times Cited: 12
Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 4
Clozapine pharmacovigilance in Croatia: underreporting of specific adverse drug reactions and excellent reporting of suicide attempts
José de León, Marina Šagud, Emílio J. Sanz, et al.
Psychiatry Research (2025), pp. 116408-116408
Closed Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis
Nazar Kuzo, Marianna Piras, Ulrich Lutz, et al.
Pharmacopsychiatry (2025)
Closed Access
Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature
Carlos De las Cuevas, Victoria de León-Martínez, Hilario Blasco‐Fontecilla, et al.
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 3
An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance
Trino Baptista, Mariano Motuca, Ana Serrano, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 9
A scoping review of literature on clozapine from former USSR states published in Russian language
O.O. Kirilochev, Егор Чумаков, Nazar Kuzo, et al.
Schizophrenia Research (2023) Vol. 268, pp. 38-47
Closed Access | Times Cited: 7
Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data
Carlos De las Cuevas, Emílio J. Sanz, Sara Jiménez‐Fernández, et al.
European Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 2
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial
Deanna L. Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Schizophrenia Research (2023) Vol. 268, pp. 312-322
Closed Access | Times Cited: 6
Dotting the I's and crossing the T's: A South Australian perspective on variability in troponin thresholds for myocarditis risk in clozapine treatment
Scott Clark, Lisa R. Wilton, Jessica L. Dawson, et al.
Schizophrenia Research (2023) Vol. 268, pp. 114-117
Open Access | Times Cited: 5
A case series of clozapine titrations affected by inflammatory processes
Jonathan G. Leung, Nicholas D. Allen, Matej Markota
Schizophrenia Research (2023)
Closed Access | Times Cited: 5
Clozapine safety monitoring and related research in psychiatry and neurology in South America: A scoping review
Trino Baptista, Ana Serrano, Alirio Pérez Lo Presti, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 4
Evaluation of major adverse events of clozapine based on accordance to an international titration guideline
Matthew Nuebel, Jonathan G. Leung, Christopher Hughes, et al.
Mental Health Clinician (2024) Vol. 14, Iss. 3, pp. 204-211
Open Access | Times Cited: 1
Surveillance hématologique de la clozapine : les temps sont-ils venus d’assouplir les règles ?
Hélène Verdoux, Alexis Lepetit
Annales Médico-psychologiques revue psychiatrique (2024)
Open Access
Page 1

Scroll to top